Cerebral Palsy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 2-8 years old, gender is not limited; (2) Abnormal hip joint development diagnosed by plain pelvic radiograph, and the hip joint grade is between grade II and III according to the Tönnis X-ray grading criteria; (3) Cardiopulmonary tolerance, able to cooperate with the completion of follow-up; (4) Voluntarily participate in this study, and the informed consent form signed by himself or his legal representative.
Exclusion criteria
Exclusion criteria: (1) Systemic diseases that may interfere with the treatment of the child or interfere with the compliance of the child; (2) Diseases that may be life-threatening in combination with various organ systems; (3) Fracture or abnormal bone mineral density and hypertonia; (4) Children who are infected with infectious diseases and have local skin infections or injuries; (5) Those who have participated in other clinical studies/investigators in the past 3 months; (6) Other serious neuromuscular system diseases; (7) Those who are considered by the investigator to be inappropriate for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor function assessment;Hip joint structural assessment;Hip joint functional assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain assessment;Quality of life;Sleep quality assessment;Family impact assessment; | — |
Countries
China
Contacts
The First Affiliated Hospital of Anhui Medical University